Patents by Inventor Anna Bladstrom

Anna Bladstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nalmefene for reduction of alcohol consumption in specific target populations
    Patent number: 10034874
    Abstract: The present invention relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who has a high drinking risk level. The present invention also relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who maintains a high DRL after an observation period following initial assessment.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: July 31, 2018
    Assignee: H. Lundbeck A/S
    Inventors: Lars Torup, Afsaneh Abbariki, Anna Bladstrom, Christine Persson, Didier Meulien, Per Sorensen, Thomas Jon Jensen, Jette Buch Ostergaard
  • NALMEFENE FOR REDUCTION OF ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS
    Publication number: 20180028526
    Abstract: The present invention relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who has a high drinking risk level. The present invention also relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who maintains a high DRL after an observation period following initial assessment.
    Type: Application
    Filed: March 22, 2017
    Publication date: February 1, 2018
    Inventors: Lars TORUP, Afsaneh ABBARIKI, Anna BLADSTROM, Christine PERSSON, Didier MEULIEN, Per SORENSEN, Thomas Jon JENSEN, Jette Buch OSTERGAARD
  • Nalmefene for reduction of alcohol consumption in specific target populations
    Publication number: 20140005217
    Abstract: The present invention relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who has a high drinking risk level. The present invention also relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who maintains a high DRL after an observation period following initial assessment.
    Type: Application
    Filed: June 26, 2013
    Publication date: January 2, 2014
    Inventors: Lars Torup, Afsaneh Abbariki, Anna Bladstrom, Christine Persson, Didier Meulien, Per Sorensen, Thomas Jon Jensen, Jette Buch Ostergaard